Traficet-EN (CCX282-B), an orally active inhibitor of chemokine receptor CCR9, for treatment of Crohn's disease

Traficet-EN (CCX282-B), an orally active inhibitor of chemokine receptor CCR9, for treatment of Crohn's disease

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Bekker, P, Velde, A, Pronk, I, Keshav, S, Hommes, D, Hanauer, S, Ungashe, S, Zheng, W, Wright, K, Schall, T
Formáid:	Conference item
Foilsithe / Cruthaithe:	2007

Míreanna comhchosúla

Ccx282-B, an orally active inhibitor of chemokine receptor Ccr9, shows anti-inflammatory and clinical activity in the treatment of Crohn's disease
de réir: Keshav, S, et al.
Foilsithe / Cruthaithe: (2007)

PROTECT-1 Maintenance Phase Study Results demonstrate efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Crohn's Disease
de réir: Bekker, P, et al.
Foilsithe / Cruthaithe: (2009)

PROTECT-1 Study Demonstrated Efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Treatment of Patients with Moderate to Severe Crohn's Disease
de réir: Keshav, S, et al.
Foilsithe / Cruthaithe: (2009)

PROTECT-1: A prospective randomized trial of CCX282-B (Traficet-EN), a novel oral therapy targeting chemokine receptor 9 in Crohn's disease
de réir: Keshav, S, et al.
Foilsithe / Cruthaithe: (2007)

Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease.
de réir: Walters, M, et al.
Foilsithe / Cruthaithe: (2010)

Protect-1, a prospective randomized oral therapy evaluation of CCX282-B (Traficet-EN) in Crohn's disease trial
de réir: Bekker, P, et al.
Foilsithe / Cruthaithe: (2008)

MEDI 167-Discovery of the highly potent, selective and orally bioavailable CCR9 antagonist CCX282-B
de réir: Ungashe, S, et al.
Foilsithe / Cruthaithe: (2008)

A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease.
de réir: Satish Keshav, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Traficet-EN, an Oral CCR9-Specific Antagonist, induces high levels of remission in the open-label Phase of PROTECT-1 in Crohn's Disease
de réir: Bekker, P, et al.
Foilsithe / Cruthaithe: (2008)

Traficet-EN, an oral CCR9-specific antagonist, induces high levels of remission in the open-label phase of PROTECT-1 in Crohn's disease
de réir: Bekker, P, et al.
Foilsithe / Cruthaithe: (2008)

Pharmacological inhibition of CCR9 is a novel approach in the treatment of inflammatory bowel disease
de réir: Bekker, P, et al.
Foilsithe / Cruthaithe: (2007)

Cc chemokine receptor 9 (ccr9) antagonist ameliorates experimental ileitis and colitis
de réir: Wei, Z, et al.
Foilsithe / Cruthaithe: (2005)

Expression of CCR8 and CCX-CKR on Basophils in Chronic Urticaria Is Amplified by IgE-Mediated Activation
de réir: Ewa A. Bartko, et al.
Foilsithe / Cruthaithe: (2023-05-01)

Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19.
de réir: Daniel Clark Files, et al.
Foilsithe / Cruthaithe: (2022-06-01)

CCR9 Antagonists in the Treatment of Ulcerative Colitis
de réir: Pirow Bekker, et al.
Foilsithe / Cruthaithe: (2015-01-01)

CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity.
de réir: Kathleen M C Sullivan, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Role of the chemokine receptors CCR1, CCR2 and CCR4 in the pathogenesis of experimental dengue infection in mice.
de réir: Rodrigo Guabiraba, et al.
Foilsithe / Cruthaithe: (2010-01-01)

Molecular insights into ligand recognition and activation of chemokine receptors CCR2 and CCR3
de réir: Zhehua Shao, et al.
Foilsithe / Cruthaithe: (2022-05-01)

CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease.
de réir: Wendt, E, et al.
Foilsithe / Cruthaithe: (2015)

Correction: Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study.
de réir: Pirow Bekker, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Expression and function of the chemokine receptor CCR7 in thyroid carcinomas.
de réir: Sancho, M, et al.
Foilsithe / Cruthaithe: (2006)

Non-redundant roles of the CCR1 and CCR2 chemokine axes in monocyte recruitment during lung metastasis
de réir: Alessia G. Liner, et al.
Foilsithe / Cruthaithe: (2025-01-01)

The chemokine receptor CCR5: multi-faceted hook for HIV-1
de réir: Natacha Faivre, et al.
Foilsithe / Cruthaithe: (2024-01-01)

In Silico Identification of Cholesterol Binding Motifs in the Chemokine Receptor CCR3
de réir: Evan van Aalst, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Structural basis of dimerization of chemokine receptors CCR5 and CXCR4
de réir: Daniele Di Marino, et al.
Foilsithe / Cruthaithe: (2023-10-01)

Chemokine receptor CCR3 is important for migration of mast cells in neurofibroma
de réir: Wei-Chun Tai, et al.
Foilsithe / Cruthaithe: (2010-12-01)

Intragenus (Homo) variation in a chemokine receptor gene (CCR5).
de réir: Kara C Hoover
Foilsithe / Cruthaithe: (2018-01-01)

Chemokines and myeloid cell recruitment.
de réir: Greaves, D, et al.
Foilsithe / Cruthaithe: (2000)

Upregulation of expression of the chemokine receptor CCR5 by hydrogen peroxide in human monocytes
de réir: Geneviève Lehoux, et al.
Foilsithe / Cruthaithe: (2003-01-01)

Mutant Chemokine Receptor (CCR-5) and Its Relevance to HIV Infection in Arabs
de réir: Iman H. Al-Sheikh, et al.
Foilsithe / Cruthaithe: (1999-02-01)

Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease
de réir: Shaoping She, et al.
Foilsithe / Cruthaithe: (2022-02-01)

The herpesvirus 8-encoded chemokine vMIP-II, but not the poxvirus-encoded chemokine MC148, inhibits the CCR10 receptor.
de réir: Lüttichau, H, et al.
Foilsithe / Cruthaithe: (2001)

Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis
de réir: Yamaguchi Kazuhiro, et al.
Foilsithe / Cruthaithe: (2009-08-01)

CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells.
de réir: Greaves, D, et al.
Foilsithe / Cruthaithe: (1997)

Abduction of chemokine elements by herpesviruses
de réir: Dairaghi, D, et al.
Foilsithe / Cruthaithe: (1998)

Arylsulfatases and neuraminidases modulate engagement of CCR5 by chemokines by removing key electrostatic interactions
de réir: Inês Pinheiro, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Chemokine CCL19 and Its Receptors CCR7 and CCRL1 in Chronic Rhinosinusitis
de réir: Mahomva CR, et al.
Foilsithe / Cruthaithe: (2024-05-01)

Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma
de réir: Annette Gilchrist, et al.
Foilsithe / Cruthaithe: (2022-03-01)

Chemokine Receptor CCR7 Triggers an Endomembrane Signaling Complex for Spatial Rac Activation
de réir: Julia M. Laufer, et al.
Foilsithe / Cruthaithe: (2019-10-01)

CCR5 genotype and plasma ß-chemokine concentration of Brazilian HIV-infected individuals
de réir: Mikawa A.Y., et al.
Foilsithe / Cruthaithe: (2002-01-01)